Hematology Analyzer
Award Notice Posted
- Solicitation number
- W81K00-25-F-A127
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Awarded
- to Sysmex America, Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- V797D40235-W81K00-25-F-A127 Federal contract award
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Place of performance
- Fort Irwin, California, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of the Army Medical Command awarded a sole-source contract valued at $400,894.20 to Sysmex America, Inc. for a hematology analyzer on July 16, 2025. The contract was awarded non-competitively because Sysmex was determined to be the only vendor capable of meeting all requirements, specifically the ability to provide complete hematological analysis using 100 microliters or less of blood sample and offering a 6-part differential capability. This reduced sample volume requirement is critical for the government facility's work with infants, pediatric patients, and those with limited venous access, while the 6-part differential allows pathologists at William Beaumont in El Paso, Texas to remotely evaluate detailed hematological abnormalities. Although Beckman Coulter also responded to the sources sought notice posted on April 28, 2025, they were unable to meet all Statement of Work requirements and indicated the specifications appeared vendor-specific.
Notice text
The contract action was not awarded competitively.
Sysmex is the only vendor known that can support all requirements set forth in the Statement Of Work (SOW). Sysmex is able to provide 100 uL or less of sample which other competitors are unable to provide. The advantage to the Government is large blood volumes (especially from infants, pediatric patients, or those with limited venous access) that can be difficult, and the Weed facility is very small with limited space. A smaller sample volume requirement allows for complete hematological analysis without compromising the patient. Also, the reduced sample volume can streamline the workflow in laboratories, minimizing handling and reducing the risk of errors associated with sample preparation and transfer.
Sysmex offers a 6-part differential which is what the Government requires. A 6-part differential (adding eosinophils, basophils, and lymphocytes subpopulations) offers significantly improved resolution, allowing for more precise identification of specific hematological abnormalities allowing pathologists to see and evaluate differential. It is important for the Government because the pathologist is at William Beaumont in El Paso, TX, and having the ability to send this information over is important. The principle also applies to body fluids.
A sources sought was posted on 28 April 2025 with capability statements due on 5 May 2025. Sysmex and Beckman Coulter replied with capabilities statements. Sysmex is fully capable. Beckman Coulter couldn’t meet all requirements from the SOW. Beckman Coulter stated the draft SOW posted with the sources sought notice was specific to a competitor. The contract specialist requested the Beckman Coulter to identify which portion(s) of the draft SOW were vendor specific. The contract specialist contacted the Contracting Officer’s Representative (COR) regarding the issues. The COR stated the SOW cannot be changed without reducing capabilities of the hematology section.
Awarded contract V797D40235 to SYSMEX AMERICA, INC for 400894.20 on 2025-07-16.
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| Notice of Intent to Sole Source: Hematology Analyzer | Special Notice | |
| Hematology Analyzer | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity